Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01984710 · ClinicalTrials.gov registry record · NA

Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S

A NA study of Treatment-Resistant Depression, sponsored by Emory University.

Active
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT01984710 is a NA study of Treatment-Resistant Depression that is active but no longer recruiting, run by Emory University. The registered enrollment target is 10 participants, below the 374-participant average among 54 other Treatment-Resistant Depression trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01984710, a NA study of Treatment-Resistant Depression, is active but no longer recruiting, sponsored by Emory University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to use the Activa Primary Cell + Sensing (PC+S) device to study Latent Field Potential (LFP) in the brains of people with Treatment Resistant Depression (TRD) before and during active stimulation. The ultimate goal is to understand the neural network that causes TRD and the changes that DBS cause in that network that results in the antidepressant effects.

Conditions Studied

Treatment-Resistant Depression

Interventions

  • DEVICE Medtronic Activa PC+S System

Study Locations (1)

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2013-09
Est. Completion 2029-01
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01984710

The ClinicalTrials.gov registry entry for NCT01984710 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 374-participant average among 54 other Treatment-Resistant Depression trials with a reported enrollment target (97% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Treatment-Resistant Depression appearing as the primary indexed condition, and to 1 intervention - of which Medtronic Activa PC+S System is the first listed.

NCT01984710 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT01984710 about?

NCT01984710 is a clinical study titled "Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S". The goal of this study is to use the Activa Primary Cell + Sensing (PC+S) device to study Latent Field Potential (LFP) in the brains of people with Treatment Resistant Depression (TRD) before and during active stimulation. The ultimate goal is to understand the neural network that causes TRD and the...

What is the current status of trial NCT01984710?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2013-09. Estimated completion is 2029-01.

What conditions does trial NCT01984710 study?

This clinical trial studies the following conditions: Treatment-Resistant Depression.

What interventions are being tested in trial NCT01984710?

The interventions under investigation include: Medtronic Activa PC+S System (DEVICE).

Who is sponsoring clinical trial NCT01984710?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01984710 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Treatment-Resistant Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Treatment-Resistant Depression

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.